At NINGBO INNO PHARMCHEM CO.,LTD., safety is paramount in the handling and supply of all chemical products. This article details the safety profile of 2,7-Dihydroxy-4-Methylquinoline (CAS 20513-71-7), offering guidance on appropriate handling, storage, and precautionary measures for its effective and safe use in laboratories and industrial settings.

2,7-Dihydroxy-4-Methylquinoline, a valuable pharmaceutical intermediate, is classified with certain hazard statements that necessitate careful attention. According to safety data sheets, it is identified as an irritant. The primary hazard statements associated with this compound include H315 (Causes skin irritation), H319 (Causes serious eye irritation), and H335 (May cause respiratory irritation). These classifications indicate that direct contact with skin, eyes, or inhalation of dust/vapors should be avoided.

To mitigate these risks, standard laboratory safety practices must be rigorously followed. Precautionary statements provide essential guidance for safe handling. These typically include P261 (Avoid breathing dust/fume/gas/mist/vapors/spray), P271 (Use only outdoors or in a well-ventilated area), P280 (Wear protective gloves/protective clothing/eye protection/face protection), and P305+P351+P338 (IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing). Adherence to these protocols is crucial when working with 2,7-Dihydroxy-4-Methylquinoline.

When considering to buy 2,7-dihydroxy-4-methylquinoline, it is imperative to obtain and review the full Safety Data Sheet (SDS) provided by the 2,7-dihydroxy-4-methylquinoline suppliers. NINGBO INNO PHARMCHEM CO.,LTD. ensures that comprehensive SDS are available for all our products, detailing physical and chemical properties, toxicological information, and emergency procedures. Understanding the specific CAS 20513-71-7 properties from a safety perspective is as important as understanding its synthetic utility.

Proper storage is also key to maintaining the compound's integrity and ensuring safety. 2,7-Dihydroxy-4-Methylquinoline should be stored in a cool, dry, and well-ventilated area, away from incompatible materials. Keeping containers tightly closed when not in use helps prevent moisture absorption and contamination, preserving its quality for downstream pharmaceutical intermediates applications.

NINGBO INNO PHARMCHEM CO.,LTD. is committed to the safe and responsible supply of chemicals. Our 2,7-dihydroxy-4-methylquinoline synthesis process includes strict safety protocols, and we ensure that our packaging and shipping procedures comply with all relevant regulations. We believe that a thorough understanding of safety data, coupled with responsible handling practices, contributes significantly to the successful and secure utilization of this important chemical intermediate.

In conclusion, while 2,7-Dihydroxy-4-Methylquinoline offers significant value as a pharmaceutical intermediate and pH indicator, its safe handling is essential. By adhering to the provided safety guidelines and consulting SDS, users can confidently and securely work with this compound. NINGBO INNO PHARMCHEM CO.,LTD. remains a trusted resource for high-quality chemicals, backed by a strong commitment to safety and customer support.